Response to Comments on “Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties”

Cyclooxygenase (COX)-3, a novel COX splice variant, was suggested as the key to unlocking the mystery of the mechanism of action of acetaminophen. Although COX-3 might have COX activity in canines, and this activity might be inhibited by acetaminophen, its low expression level and the kinetics indicate unlikely clinical relevance. In rodents and humans, COX-3 encodes proteins with completely different amino acid sequences than COX-1 or COX-2 and without COX activity; therefore, it is improbable that COX-3 in these species plays a role in prostaglandin-mediated fever and pain. The aim of this review is to evaluate the literature that seeks to point out critical theoretical and methodological limitations of the COX-3 studies that led several investigators to scientifically questionable conclusions.

[1]  G. Graham,et al.  Mechanism of Action of Paracetamol , 2005, American journal of therapeutics.

[2]  D. Simmons Variants of cyclooxygenase-1 and their roles in medicine. , 2003, Thrombosis research.

[3]  R. Botting,et al.  Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition , 2004, Pharmacological Reviews.

[4]  D. Busija,et al.  Acetaminophen-sensitive prostaglandin production in rat cerebral endothelial cells. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  N. V. Chandrasekharan,et al.  COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Busija,et al.  Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties , 2005, Journal of Pharmacology and Experimental Therapeutics.

[7]  Joshua Tomsik,et al.  Comments on “Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties” , 2005, Journal of Pharmacology and Experimental Therapeutics.